ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



A retrospective comparative study: Novel diagnostical markers of inflammation and cardiovascular risk for bipolar disorder and manic episode Running Title: Novel inflammatory markers in bipolar disorder

Elif Özcan Tozoğlu.



Abstract
Download PDF Cited by 0 ArticlesPost

Objective
Pan-immune inflammation value (PIV),inflammation burden index (IBI) and atherogenic index of plasma (AIP), neutrophil/ high-density lipoprotein (HDL) raito (NHR), lymphocyte/HDL ratio (LHR), monocyte/HDL ratio (MHR) and platelet/HDL ratio (PHR) have been recently investigated as novel inflammatory and cardiovascular markers. The aim of our study was to compare these indices with the manic episode and remission period of bipolar disorder (BD) patients with controls and to investigate the relationship between these indices and the clinical characteristics of the patients and whether these indices can be biomarkers for the disease and manic episode.
Methods
In this retrospective observational study, data were collected from 66 patients in remission, 67 patients in manic episode and 70 controls. Differences in PIV, IBI, AIP, NHR, MHR, LHR and PHR were analyzed, logistic regression analysis was performed to identify predictors of manic episodes, and the diagnostic potential of these parameters was evaluated using ROC curves.
Results
Significant differences were found between the three groups in NHR (p

Key words: pan-immune-inflammation value; inflammatory burden index; atherogenic index of plasma; bipolar disorder; biomarker







Bibliomed Article Statistics

12
70
22
14
14
12
16
24
R
E
A
D
S

9

151

22

10

24

14

13

17
D
O
W
N
L
O
A
D
S
0506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.